OUI enables patient-centred outcomes of diabetes to advance treatment
OUI's diabetes outcome measures provide insight into how diabetes affects daily life beyond clinical indicators.
Publication date: 1 June 2026
The way diabetes is measured is changing. While clinical indicators such as blood glucose levels and other clinical indicators remain important, researchers, healthcare providers and regulators increasingly recognise the need to understand how diabetes affects people’s daily lives, self-management behaviours and interactions with healthcare technologies.
Oxford University Innovation (OUI) manages a portfolio of diabetes-specific outcome measures designed to provide this broader perspective.
The Diabetes Health Profile (DHP-18) is a validated patient-reported outcome measure that captures the psychosocial and behavioural impact of living with diabetes. Measuring psychological distress, barriers to activity and disinhibited eating, DHP-18 is supported by an extensive evidence base spanning nearly three decades and more than 15,000 patients. Published studies have demonstrated reliability, validity and responsiveness, supporting its use as a patient-centred endpoint in clinical trials and outcomes research.
Complementing the DHP-18, HASMID-10 (Health and Self-Management in Diabetes) focuses on the impact of diabetes on everyday health and self-management. The measure is particularly relevant for interventions aimed at improving patient engagement, behaviour change and long-term disease management.
As diabetes care becomes increasingly technology-enabled, the Diabetes Self-Management Technology Questionnaire (DSMT-Q) provides a way to assess patient experience of diabetes technologies, including glucose monitoring systems, insulin delivery devices and connected digital solutions. Understanding how people interact with these technologies is becoming increasingly important as healthcare systems seek to improve adoption, adherence and real-world effectiveness.
Together, these OUI measures offer researchers and innovators a comprehensive toolkit for evaluating patient-centred outcomes across clinical trials, digital health programmes, real-world evidence studies and health technology assessments.
By capturing psychological wellbeing, self-management and technology experience alongside clinical outcomes, our Clinical Outcome Assessments portfolio for diabetes helps organisations generate evidence that reflects what matters most to people living with diabetes, supporting advancements in treatment and bringing benefit to those with the condition.